BELLEVUE, Wash., March 08, 2022–(Business WIRE)–Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Business” or “Novo”), pioneering a holistic technique to client-very first health and wellness by means of a multidisciplinary healthcare ecosystem of products and services and products innovation, nowadays introduced that its wholly owned subsidiary, Novo Healthnet Confined, has been granted a Natural Solution Amount (NPN) by Wellness Canada for its IoNovo Iodide branded product. A NPN is a solution license assessed and granted by Health and fitness Canada for Natural Wellbeing Products decided to be safe and sound, powerful, of substantial top quality, and suitable for sale in Canada.
IoNovo Iodide is Novo’s 3rd iodine similar product or service to lately be granted a NPN by Overall health Canada following both IoNovo Iodine and IoNovo for Youngsters pure iodine oral spray. The IoNovo item strains are created, made, and sold by Terragenx Inc., a not long ago obtained wholly-owned Novo subsidiary.
For a long time, the world health-related group has regarded iodide as an critical micronutrient that assists the thyroid to develop T3 and T4 hormones required for a healthy fat burning capacity, immune method, greater strength levels, and cognitive improvement. Furthermore, iodide is acknowledged to promote healthful pores and skin, nails, and hair. IoNovo Iodide is specifically absorbed into the bloodstream by means of a specific oral spray dosage without the need of interacting with the oral micro-biome or any microbes or viruses.
All of Novo’s IoNovo solutions are made to be shipped via oral spray which is tested to be significantly extra productive in absorption than tablet or gel capsules. IoNovo Iodide and IoNovo Iodine are offered for purchase on the Terragenx e-commerce web site (www.terragenx.com).
About Novo Integrated Sciences, Inc.
Novo Built-in Sciences, Inc. is groundbreaking a holistic solution to client-to start with overall health and wellness by a multidisciplinary healthcare ecosystem of numerous individual and customer touchpoints for solutions and products innovation. Novo provides an crucial and differentiated solution to provide, or intend to produce, these providers and goods as a result of the integration of healthcare technological innovation, innovative therapeutics, and rehabilitative science.
We think that “decentralizing” health care, by the integration of clinical engineering and interconnectivity, is an vital remedy to the speedily evolving essential transformation of how non-catastrophic healthcare is delivered each now and in the long run. Distinct to non-crucial treatment, ongoing progress in both of those healthcare technology and inter-connectivity are enabling for a shift of the individual/practitioner marriage to the patient’s household and absent from on-site visits to major healthcare facilities with mass-products and services. This acceleration of “simplicity-of-accessibility” in the affected individual/practitioner conversation for non-significant care prognosis and subsequent procedure minimizes the degradation of non-important wellness conditions to critical problems as effectively as making it possible for for far more price-productive healthcare distribution.
The Company’s decentralized healthcare business enterprise model is centered on a few main pillars to best help the transformation of non-catastrophic healthcare shipping to patients and buyers:
Initial Pillar: Service Networks. Deliver multidisciplinary major care solutions by way of (i) an affiliate community of clinic amenities, (ii) smaller and micro footprint sized clinic facilities mostly positioned in just the footprint of box-shop industrial enterprises, (iii) clinic amenities operated through a franchise connection with the Organization, and (iv) company operated clinic facilities.
2nd Pillar: Engineering. Build, deploy, and combine refined interconnected technological know-how, interfacing the client to the healthcare practitioner so growing the reach and availability of the Company’s services, beyond the regular clinic area, to geographic parts not readily providing advanced, peripheral dependent healthcare companies, which includes the patient’s property.
Third Pillar: Goods. Create and distribute productive, individualized overall health and wellness solution answers enabling for the customization of patient preventative treatment remedies and finally a more healthy inhabitants. The Company’s science-to start with technique to product or service innovation even more emphasizes our mandate to create and provide in excess of-the-counter preventative and routine maintenance treatment methods.
Innovation by way of science blended with the integration of innovative, protected know-how assures Novo Integrated Sciences of ongoing reducing-edge advancement in individual 1st platforms.
For more details relating to Novo Integrated Sciences, make sure you visit www.novointegrated.com . For much more data on Novo Healthnet Constrained, Novo’s wholly owned subsidiary, you should go to www.novohealthnet.com.
This push launch is made up of forward-searching statements within the meaning of Segment 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Trade Act of 1934, as amended. All statements other than statements of historic points provided in this push release are ahead-searching statements. In some situations, ahead-on the lookout statements can be discovered by terms these types of as “believe that,” “intend,” “be expecting,” “anticipate,” “approach,” “prospective,” “carry on” or similar expressions. Such ahead-hunting statements include pitfalls and uncertainties, and there are crucial elements that could trigger true final results to differ materially from all those expressed or implied by these types of forward-on the lookout statements. These variables, challenges and uncertainties are mentioned in Novo’s filings with the Securities and Exchange Commission. Buyers really should not put any undue reliance on forward-searching statements considering that they contain recognized and mysterious, uncertainties and other components which are, in some cases, beyond Novo’s command which could, and probably will, materially have an impact on true success, concentrations of action, overall performance or achievements. Any forward-wanting assertion displays Novo’s present sights with respect to foreseeable future situations and is topic to these and other dangers, uncertainties and assumptions relating to operations, benefits of operations, growth tactic and liquidity. Novo assumes no obligation to publicly update or revise these forward-searching statements for any explanation, or to update the reasons real benefits could vary materially from those people expected in these forward-searching statements, even if new data will become obtainable in the potential. The contents of any internet site referenced in this push launch are not included by reference herein.
See resource edition on businesswire.com: https://www.businesswire.com/news/home/20220308005407/en/
Chris David, COO-President
Novo Built-in Sciences, Inc.